These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 27477274)

  • 1. The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells.
    Jin X; Jeon HM; Jin X; Kim EJ; Yin J; Jeon HY; Sohn YW; Oh SY; Kim JK; Kim SH; Jung JE; Kwak S; Tang KF; Xu Y; Rich JN; Kim H
    Cell Rep; 2016 Aug; 16(6):1629-1641. PubMed ID: 27477274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc.
    Kim EJ; Kim SH; Jin X; Jin X; Kim H
    Cell Death Differ; 2017 Apr; 24(4):649-659. PubMed ID: 28060381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
    Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
    Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
    [No Abstract]   [Full Text] [Related]  

  • 4. RYK promotes the stemness of glioblastoma cells via the WNT/ β-catenin pathway.
    Adamo A; Fiore D; De Martino F; Roscigno G; Affinito A; Donnarumma E; Puoti I; Ricci Vitiani L; Pallini R; Quintavalle C; Condorelli G
    Oncotarget; 2017 Feb; 8(8):13476-13487. PubMed ID: 28086236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
    Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
    Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AURKA governs self-renewal capacity in glioma-initiating cells via stabilization/activation of β-catenin/Wnt signaling.
    Xia Z; Wei P; Zhang H; Ding Z; Yang L; Huang Z; Zhang N
    Mol Cancer Res; 2013 Sep; 11(9):1101-11. PubMed ID: 23761169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cox-2-derived PGE2 induces Id1-dependent radiation resistance and self-renewal in experimental glioblastoma.
    Cook PJ; Thomas R; Kingsley PJ; Shimizu F; Montrose DC; Marnett LJ; Tabar VS; Dannenberg AJ; Benezra R
    Neuro Oncol; 2016 Oct; 18(10):1379-89. PubMed ID: 27022132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTK7 regulates Id1 expression in CD44-high glioma cells.
    Liu Q; Zhang C; Yuan J; Fu J; Wu M; Su J; Wang X; Yuan X; Jiang W
    Neuro Oncol; 2015 Apr; 17(4):505-15. PubMed ID: 25204555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. USP1 targeting impedes GBM growth by inhibiting stem cell maintenance and radioresistance.
    Lee JK; Chang N; Yoon Y; Yang H; Cho H; Kim E; Shin Y; Kang W; Oh YT; Mun GI; Joo KM; Nam DH; Lee J
    Neuro Oncol; 2016 Jan; 18(1):37-47. PubMed ID: 26032834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cell-penetrating peptide based on the interaction between c-Src and connexin43 reverses glioma stem cell phenotype.
    Gangoso E; Thirant C; Chneiweiss H; Medina JM; Tabernero A
    Cell Death Dis; 2014 Jan; 5(1):e1023. PubMed ID: 24457967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K inhibitor combined with miR-125b inhibitor sensitize TMZ-induced anti-glioma stem cancer effects through inactivation of Wnt/β-catenin signaling pathway.
    Shi L; Fei X; Wang Z; You Y
    In Vitro Cell Dev Biol Anim; 2015 Nov; 51(10):1047-55. PubMed ID: 26170223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteins of Wnt signaling pathway in cancer stem cells of human glioblastoma.
    Shevchenko V; Arnotskaya N; Zaitsev S; Sharma A; Sharma HS; Bryukhovetskiy A; Pak O; Khotimchenko Y; Bryukhovetskiy I
    Int Rev Neurobiol; 2020; 151():185-200. PubMed ID: 32448607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ISL1 Promotes Human Glioblastoma-Derived Stem Cells' Self-Renewal by Activation of Sonic Hedgehog/GLI1 Function.
    Liu Y; Luan Y; Ma K; Zhang Z; Liu Y; Chen X
    Stem Cells Dev; 2022 May; 31(9-10):258-268. PubMed ID: 35403434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Gli2 suppresses tumorigenicity in glioblastoma stem cells derived from a de novo murine brain cancer model.
    Tanigawa S; Fujita M; Moyama C; Ando S; Ii H; Kojima Y; Fujishita T; Aoki M; Takeuchi H; Yamanaka T; Takahashi Y; Hashimoto N; Nakata S
    Cancer Gene Ther; 2021 Dec; 28(12):1339-1352. PubMed ID: 33414520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt3a mediated activation of Wnt/β-catenin signaling promotes tumor progression in glioblastoma.
    Kaur N; Chettiar S; Rathod S; Rath P; Muzumdar D; Shaikh ML; Shiras A
    Mol Cell Neurosci; 2013 May; 54():44-57. PubMed ID: 23337036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ID1 affects the efficacy of radiotherapy in glioblastoma through inhibition of DNA repair pathways.
    Guo Q; Guo P; Mao Q; Lan J; Lin Y; Jiang J; Qiu Y
    Med Oncol; 2013 Mar; 30(1):325. PubMed ID: 23377983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
    Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
    Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
    Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
    Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
    Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
    Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.